The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding.

The alpha-glucosidase inhibitor N-butyldeoxynojirimycin (NB-DNJ) is a potent inhibitor of human immunodeficiency virus (HIV) replication and syncytium formation in vitro. However, the exact mechanism of action of NB-DNJ remains to be determined. In this study we have examined the impairment of HIV i...

Celý popis

Podrobná bibliografie

Vydáno v:	J Virol
Hlavní autoři:	Fischer, P B, Collin, M, Karlsson, G B, James, W, Butters, T D, Davis, S J, Gordon, S, Dwek, R A, Platt, F M
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Microbiology (ASM) 1995
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC189444/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7543588/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.69.9.5791-5797.1995
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!